Home › Scleroderma › Ohio
Pag-aaral pangklinika para sa Scleroderma sa Ohio
4 pag-aaral para sa Scleroderma ang naghahanap ng mga kalahok sa mga site sa Ohio.
Opisyal na teksto ng pag-aaral (English)
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Ohio State University Comprehensive Cancer Center, Columbus
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT03816345A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
- GSK Investigational Site, Cincinnati
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT05878717A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- MetroHealth, Cleveland
Nagre-recruitPhase 1
Edad 12 hanggang 70 · Lahat ng kasarian · Na-update May 22, 2026 · NCT06308978Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
- aTyr Investigative Site, Cleveland
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update May 7, 2025 · NCT05892614Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.